NCT06915857View on ClinicalTrials.gov

Topical Betamethasone Versus Moisturizer in Preventing Radiation Dermatitis in Large-Breasted Patients Treated in the Prone Position

PHASE3RecruitingINTERVENTIONAL

Enrollment

276

Participants

Timeline

Start Date

February 26, 2025

Primary Completion Date

September 6, 2026

Study Completion Date

December 6, 2026

Conditions

Breast CancerRadiation Dermatitis

Interventions

DEVICE

Topical Betamethasone

Betamethasone a TC, reduces RD by promoting the synthesis of anti-inflammatory proteins while also preventing other inflammatory proteins from being synthesized

Trial Locations (1)

M4N 3M5

RECRUITING

Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto

All Listed Sponsors

lead

Sunnybrook Health Sciences Centre

OTHER